Missing BsUFA Revenue Trigger Could Open US FDA Staff To Criminal Penalty

 
• By Derrick Gingery
  
Staffing cuts at the FDA could threaten its ability to collect biosimilar user fees. (Shutterstock)

More from User Fees

More from Pathways & Standards